WHO endorses Lenacapavir, breakthrough HIV drug that offers near-total protection with two doses a year
By Jeremy Fregene A major breakthrough in HIV prevention has been achieved, as the World Health Organisation (WHO) has endorsed lenacapavir (LEN), a twice-yearly injectable drug that provides near-total protection against HIV. The landmark announcement was made on Monday 14 July, 2025, during the 13th International AIDS Society (IAS 2025) Conference on HIV Science, taking…